Robert J. Mulroy
2012
In 2012, Robert J. Mulroy earned a total compensation of $4M as President and Chief Executive Officer at Merrimack Pharmaceuticals, a 414% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $222,750 |
---|---|
Option Awards | $3,322,500 |
Salary | $465,820 |
Other | $12,522 |
Total | $4,023,592 |
Mulroy received $3.3M in option awards, accounting for 83% of the total pay in 2012.
Mulroy also received $222.8K in non-equity incentive plan, $465.8K in salary and $12.5K in other compensation.
Rankings
In 2012, Robert J. Mulroy's compensation ranked 1,629th out of 11,487 executives tracked by ExecPay. In other words, Mulroy earned more than 85.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,629 out of 11,487 | 86th |
Division Manufacturing | 584 out of 4,253 | 86th |
Major group Chemicals And Allied Products | 129 out of 1,198 | 89th |
Industry group Drugs | 69 out of 920 | 93rd |
Industry Pharmaceutical Preparations | 58 out of 700 | 92nd |
Source: SEC filing on March 27, 2015.
Mulroy's colleagues
We found four more compensation records of executives who worked with Robert J. Mulroy at Merrimack Pharmaceuticals in 2012.
2012
Ulrik Nielsen
Merrimack Pharmaceuticals
Chief Scientific Officer
2012
William McClements
Merrimack Pharmaceuticals
Head of Corporate Operations
2012
Edward Stewart
Merrimack Pharmaceuticals
Senior Vice President and President, Merrimack Healthcare Solutions
2012
William Sullivan
Merrimack Pharmaceuticals